Hecht, Markus 
; Gostian, Antoniu Oreste ; Eckstein, Markus ; Rutzner, Sandra ; von der Grün, Jens ; Illmer, Thomas ; Hautmann, Matthias G. ; Klautke, Gunther ; Laban, Simon ; Brunner, Thomas ; Hinke, Axel ; Becker, Ina ; Frey, Benjamin ; Semrau, Sabine ; Geppert, Carol I. ; Hartmann, Arndt ; Balermpas, Panagiotis ; Budach, Wilfried ; Gaipl, Udo S. ; Iro, Heinrich ; Fietkau, Rainer
; Gostian, Antoniu Oreste ; Eckstein, Markus ; Rutzner, Sandra ; von der Grün, Jens ; Illmer, Thomas ; Hautmann, Matthias G. ; Klautke, Gunther ; Laban, Simon ; Brunner, Thomas ; Hinke, Axel ; Becker, Ina ; Frey, Benjamin ; Semrau, Sabine ; Geppert, Carol I. ; Hartmann, Arndt ; Balermpas, Panagiotis ; Budach, Wilfried ; Gaipl, Udo S. ; Iro, Heinrich ; Fietkau, Rainer 
Abstract
Background To determine safety and efficacy of single cycle induction treatment with cisplatin/docetaxel and durvalumab/tremelimumab in stage III-IVB head and neck cancer. Methods Patients received a single cycle of cisplatin 30 mg/m(2) on days 1-3 and docetaxel 75 mg/m(2) on day 1 combined with durvalumab 1500 mg fix dose on day 5 and tremelimumab 75 mg fix dose on day 5. Patients with ...
Owner only: item control page
Altmetric